Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-022755
Filing Date
2017-09-28
Accepted
2017-09-28 17:30:37
Documents
2
Period of Report
2017-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12640
2 EX-24 DOCUMENT attachment1.htm EX-24 4603
  Complete submission text file 0000899243-17-022755.txt   18709
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE - SUITE 3502 NEW YORK NY 10036
Business Address
Ratcliffe Liam (Reporting) CIK: 0001547100 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38219 | Film No.: 171108500

Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations